An interventional study of Robot-Assisted Bronchoscopic Biopsy and Robot-Assisted Transbronchial Ablation in Pulmonary Lesions, sponsored by Shanghai Pulmonary Hospital, Shanghai, China. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Shanghai Pulmonary Hospital, Shanghai, China · Not applicable, Interventional, and Health services research
This study evaluates whether robot-assisted bronchoscopy can be used successfully and safely to obtain tissue samples and perform local treatment of lung lesions at Shanghai Pulmonary Hospital, China. Lung lesions are abnormal areas seen on lung scans. Bronchoscopy uses a thin, flexible tube passed through the airways to reach these areas. A biopsy collects tissue to help establish a diagnosis. Ablation is a local treatment intended to destroy targeted abnormal tissue.
The prospective part of the study has three stages: biopsy, an initial evaluation of ablation, and biopsy followed by ablation during the same anesthesia session. Adults enter the appropriate group according to their clinical needs and suitability for the procedure, rather than by random assignment. The need for ablation is determined before the procedure. Imaging is used to confirm the positions of the lesion and instruments, and treatment may be adjusted or stopped if safety conditions are not met.
An exploratory comparison uses existing medical records of patients who underwent biopsy and ablation through the chest wall in separate procedures. Researchers compare this staged approach with biopsy and ablation performed through the airways in one session to explore differences in treatment completion time, time spent in hospital, and procedure duration.
The main outcome for the pathway comparison is the number of days from the first hospital admission to completion of the last planned ablation procedure. Other assessments include whether biopsy provides a diagnosis, whether planned ablation is completed, changes on follow-up scans, and procedure-related complications. After ablation, participants undergo computed tomography (CT) scans at 1 and 6 months, with an additional imaging assessment at either 9 or 12 months.
Shanghai Pulmonary Hospital, Shanghai, China is the lead sponsor of 160 studies on the registry; 95 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Robot-Assisted Bronchoscopic Biopsy · Procedure: Robot-Assisted Transbronchial Ablation · Procedure: Same-Session Robot-Assisted Bronchoscopic Biopsy and Transbronchial Ablation
Image-guided tissue sampling of pulmonary lesions using Ion shape-sensing robotic-assisted bronchoscopy.
Image-guided transbronchial ablation of pulmonary lesions using Ion shape-sensing robotic-assisted bronchoscopy, with eligibility for ablation established before the procedure.
Image-guided biopsy and transbronchial ablation of pulmonary lesions using Ion shape-sensing robotic-assisted bronchoscopy during a single anaesthetic session.
Time from first hospital admission to completion of the last planned ablation
Time frame: Periprocedural period.
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2025 to primary completion in Apr 2025, 0 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Pulmonary Hospital, Shanghai, China →